| Alfred Chun Guo, DMD | |
|
104 W D L. Ingram Avenue, Apo, AA 88101 | |
| (814) 969-1999 | |
| Not Available |
| Full Name | Alfred Chun Guo |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 104 W D L. Ingram Avenue, Apo, Armed Forces Americas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538894779 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | DE61322146 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alfred Chun Guo, DMD 134 Sunny Point Cir, Lagrange, GA 30240-9715 Ph: (814) 969-1999 | Alfred Chun Guo, DMD 104 W D L. Ingram Avenue, Apo, AA 88101 Ph: (814) 969-1999 |
News Archive
AirPal, a medical device manufacturer headquartered in North Wales, Pennsylvania, has received notification of allowance from the U.S. Patent Office for its modular system of inflatable devices used to position patients for situations such as difficult airway management, laryngoscopies, diagnostic exams, surgeries, and related procedures.
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today presents compelling preclinical data in chronic obstructive pulmonary disease (COPD) for its lead product PA401 at the European Respiratory Society Congress in Barcelona, Spain. This conference is the largest gathering of scientists and clinicians in the respiratory community in the world. The Oral Presentation will be made in the session "Pre-clinical models of airways disease".
Samsung Biologics and Biogen Idec announced today that the companies have established their joint venture, Samsung Bioepis Co., Ltd., to develop, manufacture and market biosimilars in keeping with their agreement announced in December.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
› Verified 8 days ago
True Xiong, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: Zachary & Elizabeth Fisher Medical & Dental Clinic, 2470 Sampson Street, Apo, AA 60088 Phone: 847-688-3331 | |
Dr. Robert Harris Range, D.D.S Dentist Medicare: Medicare Enrolled Practice Location: Us Army Fort Drum Stone Dental Clinic, 10590 Enduring Freedom Drive, Apo, AA 13602 Phone: 315-772-5576 | |
Dr. Jacob Steven Blackhurst, DDS Dentist Medicare: Medicare Enrolled Practice Location: Bldg 4-1838 Normandy Dr, Apo, AA 28307 Phone: 910-432-6190 | |
Dr. Tad Christian Tholstrom, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 48 Mdg, Unit 5115, Apo, AA 09461 Phone: 441-480-824585 | |
Dr. Sara Kingston, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: Offutt Afb 55th Dental Squadron, 2501 Capehart Road, Apo, AA 68113 Phone: 402-232-2273 | |
Christina Belousov, DDS, MBS Dentist Medicare: Not Enrolled in Medicare Practice Location: 14351 Battalion Ave, Apo, AA 76544 Phone: 254-288-7848 | |
Samuel Jun Lee, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 21227 Torch St, Apo, AA 79918 Phone: 915-742-4248 |